OTC Markets OTCQB - Delayed Quote USD

CS Diagnostics Corp. (CSDX)

0.0675

+0.0075

+(12.32%)

As of 1:43:35 PM EDT. Market Open.

CS Group Announces the Valuation of MEDUSA Surface Disinfectant at USD 513 Million

CHEYENNE, WY AND NEUSS, GERMANY / ACCESS Newswire / April 22, 2025 / CS Group announced the completion of a comprehensive valuation for its proprietary smart surface disinfectant, MEDUSA. The valuation conducted as of April 1, 2025 estimates the fair ...

ACCESS Newswire 6 days ago

CSDX
+12.32%
CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and investment management firm based in Bogotá, Colombia ...

ACCESS Newswire 13 days ago

CSDX
+12.32%
OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval

CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS Innovative tissue spacer technology for cancer radiology treatments CHEYENNE, WY / ACCESS Newswire / March 12, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) (or "the company") is delighted ...

ACCESS Newswire last month

CSDX
+12.32%
CS Diagnostics Corp. Announces U.S. Launch of MEDUSA

NEUSS, Germany, January 21, 2025--CS Diagnostics Corp. Announces U.S. Launch of MEDUSA

Business Wire 3 months ago

CSDX
+12.32%

Performance Overview

Return	CSDX	S&P 500 (^GSPC)
YTD	-94.18%	-6.59%
1-Year	-60.87%	+7.72%
3-Year	-98.65%	+28.14%